Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.003 | 0.0884 | 0.113 |
Trichomonas vaginalis | abcb9, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0139 | 0.7813 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | ABC transporter family protein | 0.0032 | 0.0981 | 0.1256 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0032 | 0.0981 | 0.1254 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | Isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0016 | 0.0002 | 0.0002 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0.0614 | 0.0784 |
Brugia malayi | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Schistosoma mansoni | hypothetical protein | 0.003 | 0.0884 | 0.0884 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0139 | 0.7813 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0139 | 0.7813 | 0.5 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0022 | 0.0375 | 0.0375 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.1191 | 0.1191 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Schistosoma mansoni | smdr2 | 0.0032 | 0.0981 | 0.0981 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.1191 | 0.1525 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.003 | 0.0884 | 0.113 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0139 | 0.7813 | 0.5 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Mycobacterium ulcerans | proteasome PrcB | 0.0139 | 0.7813 | 0.5 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | multidrug resistance protein 3 | 0.0032 | 0.0981 | 0.1256 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1315 | 0.1315 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.1315 | 0.1315 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0139 | 0.7813 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.003 | 0.0884 | 0.113 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0139 | 0.7813 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0.0614 | 0.0784 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0022 | 0.0375 | 0.0375 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.2218 | 0.2838 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0614 | 0.0784 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.003 | 0.0884 | 0.0884 |
Toxoplasma gondii | kringle domain-containing protein | 0.003 | 0.0884 | 0.113 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.1315 | 0.1315 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0614 | 0.0784 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0884 | 0.1132 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.2218 | 0.2838 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0981 | 0.1256 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0981 | 0.1256 |
Echinococcus granulosus | tissue type plasminogen activator | 0.003 | 0.0884 | 0.0884 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0614 | 0.0784 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0026 | 0.0614 | 0.0784 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1191 | 0.1525 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Onchocerca volvulus | 0.0032 | 0.0981 | 1 | |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0959 | 0.1228 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0032 | 0.0981 | 0.1256 |
Trichomonas vaginalis | abcb9, putative | 0.0032 | 0.0981 | 0.0815 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0139 | 0.7813 | 0.7813 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0884 | 0.113 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.2218 | 0.2838 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0032 | 0.0981 | 0.1254 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0614 | 0.0786 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0.0614 | 0.0784 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.1315 | 0.1315 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0139 | 0.7813 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0032 | 0.0981 | 0.0981 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0031 | 0.0959 | 0.0959 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0139 | 0.7813 | 0.7813 |
Echinococcus granulosus | proteasome prosome macropain | 0.0139 | 0.7813 | 0.7813 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0032 | 0.0981 | 0.1256 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Leishmania major | p-glycoprotein | 0.0032 | 0.0981 | 0.1254 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0032 | 0.0981 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.2218 | 0.2838 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Brugia malayi | Kringle domain containing protein | 0.003 | 0.0884 | 0.1132 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | abcb9, putative | 0.0032 | 0.0981 | 0.0815 |
Leishmania major | ATP-binding cassette protein subfamily B, member 2, putative | 0.0032 | 0.0981 | 0.1254 |
Brugia malayi | hypothetical protein | 0.0017 | 0.0032 | 0.0042 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0614 | 0.0784 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.1254 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | Protein kinase domain containing protein | 0.003 | 0.0884 | 0.1132 |
Brugia malayi | hypothetical protein | 0.0026 | 0.0614 | 0.0786 |
Schistosoma mansoni | multidrug resistance protein | 0.0032 | 0.0981 | 0.0981 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.003 | 0.0884 | 0.1132 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0022 | 0.0375 | 0.0375 |
Brugia malayi | hypothetical protein | 0.0037 | 0.1315 | 0.1683 |
Trichomonas vaginalis | taga, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0139 | 0.7813 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0032 | 0.0981 | 0.1254 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0139 | 0.7813 | 1 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0139 | 0.7813 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0031 | 0.0959 | 0.0959 |
Schistosoma mansoni | multidrug resistance protein | 0.0032 | 0.0981 | 0.0981 |
Toxoplasma gondii | ATP-binding cassette transporter ABC.B1 | 0.0032 | 0.0981 | 0.1254 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.